Mission Bio is revolutionizing cancer research with its cutting-edge Tapestri Platform, the industry's first and only single-cell multi-omics platform. This innovative technology allows for genotype and phenotype analysis from a single cell, enabling precise detection of disease heterogeneity and treatment response. We empower researchers to understand and ultimately eradicate cancer. Our platform is at the forefront of the single-cell multi-omics space, serving major cancer centers and pharma/biopharma companies globally. Mission Bio offers a dynamic environment where collaboration, drive, and curiosity thrive. We have a diverse tech stack supporting our platform, including WordPress, Google Analytics, and various mobile-compatible technologies. We are actively expanding our global presence, with remote opportunities available in Germany and France. With a team of 101-250 employees and strong Series C funding, Mission Bio is committed to rapid growth and innovation. We're not just building technology; we're building a future free of cancer. Join our collaborative and driven team to make a real impact.